medi8852
mAbexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2015 (NCT02350751)
Timeline
Indications
Mechanism of action
- Influenza virusImmunity, passive
Influenza virus immunity, passive
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- medi8852
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03903718 | Phase 2 | Apr 16, 2019 | MedImmune |
| NCT03028909 | Phase 2 | Jul 24, 2017 | MedImmune |
| NCT02603952 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2015 | MedImmune |
| NCT02350751 | Phase 1 | Jan 1, 2015 | MedImmune |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MedImmune | For profit | 4 | 4 | 2 | 2015 |
1 organizations
Page 1 / 1